Aurinia Pharmaceuticals (AUPH) Raw Materials (2023 - 2026)

Aurinia Pharmaceuticals (AUPH) has 4 years of Raw Materials data on file, last reported at $658000.0 in Q1 2026.

• Quarterly Raw Materials fell 14.66% year-over-year to $658000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $658000.0 (down 14.66% YoY) and the FY2025 annual result came in at $658000.0, down 61.34% from the prior year.
• Raw Materials was little changed at $658000.0 in Q1 2026, from $658000.0 in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $1.7 million in Q4 2023 to a low of $658000.0 in Q4 2025.
• A 4-year average of $1.0 million and a median of $771000.0 in 2025 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2024 — Raw Materials fell 2.52% — and 2025, when it sank 61.34%.
• Tracing AUPH's Raw Materials over 4 years: stood at $1.7 million in 2023, then decreased by 2.52% to $1.7 million in 2024, then plunged by 61.34% to $658000.0 in 2025, then changed by 0.0% to $658000.0 in 2026.
• The last three Raw Materials figures came in at $658000.0 (Q1 2026), $658000.0 (Q4 2025), and $771000.0 (Q3 2025), per Business Quant data.